| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |